Luminex, Celera Diagnostics xMAP deal

Celera Diagnostics (Alameda, Calif.) received non-exclusive rights to develop and distribute in-vitro molecular diagnostics based on LMNX's xMAP bioassay technology, for use on the Luminex 100 System....